JP3935839B2 - エストラジオール含有貼付剤 - Google Patents

エストラジオール含有貼付剤 Download PDF

Info

Publication number
JP3935839B2
JP3935839B2 JP2002542404A JP2002542404A JP3935839B2 JP 3935839 B2 JP3935839 B2 JP 3935839B2 JP 2002542404 A JP2002542404 A JP 2002542404A JP 2002542404 A JP2002542404 A JP 2002542404A JP 3935839 B2 JP3935839 B2 JP 3935839B2
Authority
JP
Japan
Prior art keywords
estradiol
patch
drug
fatty acid
higher fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002542404A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2002040031A1 (ja
Inventor
享 丸尾
裕之 早稲田
伸明 花嶋
Original Assignee
帝三製薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 帝三製薬株式会社 filed Critical 帝三製薬株式会社
Publication of JPWO2002040031A1 publication Critical patent/JPWO2002040031A1/ja
Application granted granted Critical
Publication of JP3935839B2 publication Critical patent/JP3935839B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2002542404A 2000-11-17 2001-11-13 エストラジオール含有貼付剤 Expired - Fee Related JP3935839B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000350657 2000-11-17
JP2000350657 2000-11-17
PCT/JP2001/009915 WO2002040031A1 (fr) 2000-11-17 2001-11-13 Preparation adhesive contenant estradiol

Publications (2)

Publication Number Publication Date
JPWO2002040031A1 JPWO2002040031A1 (ja) 2004-03-18
JP3935839B2 true JP3935839B2 (ja) 2007-06-27

Family

ID=18823846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002542404A Expired - Fee Related JP3935839B2 (ja) 2000-11-17 2001-11-13 エストラジオール含有貼付剤

Country Status (5)

Country Link
JP (1) JP3935839B2 (fr)
KR (1) KR100533493B1 (fr)
CN (1) CN1198621C (fr)
AU (1) AU2002212763A1 (fr)
WO (1) WO2002040031A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1581156A4 (fr) * 2003-01-03 2007-03-07 Dpc Products Inc Compositions d'administration pharmaceutique derivees de gilsonite et procedes
JP7112256B2 (ja) * 2018-06-08 2022-08-03 株式会社日本触媒 粘着剤組成物及びその利用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2507068B2 (ja) * 1989-07-10 1996-06-12 積水化学工業株式会社 経皮吸収製剤
JPH0344326A (ja) * 1989-07-10 1991-02-26 Sekisui Chem Co Ltd 経皮吸収製剤
AU644815B2 (en) * 1989-09-08 1993-12-23 Ortho-Mcneil Pharmaceutical, Inc. Solid matrix system for transdermal drug delivery
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern

Also Published As

Publication number Publication date
JPWO2002040031A1 (ja) 2004-03-18
KR20040011430A (ko) 2004-02-05
CN1198621C (zh) 2005-04-27
WO2002040031A1 (fr) 2002-05-23
AU2002212763A1 (en) 2002-05-27
CN1474695A (zh) 2004-02-11
KR100533493B1 (ko) 2005-12-06

Similar Documents

Publication Publication Date Title
US6231885B1 (en) Composition for controlled and sustained transdermal administration
AU703593B2 (en) Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US6791003B1 (en) Dual adhesive transdermal drug delivery system
AU750861B2 (en) Topical plaster with non-steroidal antirheumatic agents with an acid group
US5306503A (en) Patch with a high content of softening ingredients
US5693335A (en) Skin permeation enhancer composition for use with sex steroids
JP4659943B2 (ja) 塩酸ブプレノルフィン含有貼付剤
JP4422430B2 (ja) エストロゲン及び／又はプロゲストゲン含有外用貼付剤
JPH08505632A (ja) 活性物質としてガランタミンを有する経皮医療システム
JP2004514738A (ja) 活性物質としてオキシブチニンで構成される経皮治療システム
CZ282557B6 (cs) Způsob výroby transdermálního terapeutického systému s buprenorfinem jako aktivní součástí
WO2007099966A1 (fr) Preparation pour absorption transdermique
JP2011513287A (ja) 医薬品組成物
WO2015200472A1 (fr) Système d'administration transdermique
JP5096149B2 (ja) 外用剤
JPH0667835B2 (ja) 医薬組成物
JP2002537244A (ja) デオキシペガニン経皮治療系
JP4311728B2 (ja) 経皮吸収型貼付剤
CA2172265C (fr) Dispositif d'administration transdermique contenant un oestrogene
JP3935839B2 (ja) エストラジオール含有貼付剤
CA2121991A1 (fr) Compositions de butyrophenone pour administration transdermique
JPH07103016B2 (ja) 貼付剤およびその製造方法
JPH07116025B2 (ja) 貼付剤
JP4988080B2 (ja) 経皮吸収型製剤
JP6512905B2 (ja) フェンタニル含有貼付剤

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060711

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060906

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070227

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070320

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110330

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130330

Year of fee payment: 6

LAPS Cancellation because of no payment of annual fees